Castle Biosciences Inc

+0.90 (+1.76%)
Earnings Announcements

Castle Biosciences Reports Q3 Rev Of $15.2 Mln

Published: 11/09/2020 22:26 GMT
CASTLE BIOSCIENCES INC (CSTL) - Castle Biosciences Announces Third Quarter 2020 Results.
Q3 2020 Revenues of $15.2 Million.
Qtrly Loss per Share $0.23.
As of Sept.
30, 2020, Company's Cash and Cash Equivalents Totaled $183.1 Million.
Q3 Earnings per Share View $-0.12, Revenue View $15.0 Million -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $15.86 Million
Adjusted EPS is expected to be -$0.12

Next Quarter Revenue Guidance is expected to be $17.19 Million
Next Quarter EPS Guidance is expected to be -$0.12

More details on our Analysts Page.